Clinical trial Recruiting at 1 site Observational Ages 50 to 100

Detecting Alzheimer's and mood disorders through voice analysis

Official title: Early Detection of Alzheimer's Disease and Affective Disorders by Automated Voice and Speech Analysis

Run by Centre Hospitalier Universitaire de Nice · NCT05943834 · Data updated 2026-11-12

This study is testing whether analyzing voice patterns can help detect Alzheimer's and mood disorders without needing invasive tests like spinal taps or scans.

Quick facts

Study typeObservational
Ages50 Years to 100 Years
SexAll
Enrollment100 (estimated)
SponsorCentre Hospitalier Universitaire de Nice
Academic / other
Locations1 site (Nice)
StatusRecruiting
StartedJuly 13, 2023
Main results expectedOctober 10, 2027
Study endsOctober 10, 2027
Registry record updatedMarch 19, 2026
Trial IDNCT05943834 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are individuals aged 50 and older with a diagnosis of mild cognitive impairment or very mild dementia.

Probably not a fit

Patients with significant hearing problems or those under legal protection may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

The PLATA project aims to develop an algorithm that identifies vocal biomarkers associated with Alzheimer's disease and affective disorders. By analyzing speech patterns collected during routine care, the study will compare these patterns to established biomarkers like amyloid 1-42 and p-Tau found in cerebrospinal fluid. This innovative approach could potentially eliminate the need for invasive procedures such as lumbar punctures and PET scans for early detection of these conditions.

Why it matters

Potential benefit: If successful, this study could provide a non-invasive method for early detection of Alzheimer's disease and mood disorders.

How similar studies have gone: While the approach of using vocal biomarkers is innovative, similar studies have shown promise in identifying cognitive disorders through speech analysis.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Age ≥ 50 years
* Diagnosis relevant biomarker and neuropsychological data already available
* Cognitively healthy to very mild dementia (CDR score max. 0.5)
* Sufficient knowledge of the study language to understand study information, non opposition form,and questionnaires
* Expression of non opposition

Exclusion Criteria:

* Hearing problems
* Patient protected by law, under guardianship or curator ship, or not able to participate in a clinical study according to the article L.1121-16 of the French Public Health Code

Where it's running

  • CHU de Nice
    Nice, France
    Recruiting

Study contacts

  • Principal investigator: Eric ETTORE, MD — Centre Hospitalier Universitaire de Nice
  • Study coordinator: Eric ETTORE, MD
  • Email: ettore.e@chu-nice.fr
  • Phone: 04.92.03.47.70

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.